K. Fujikawa et al. / Carbohydrate Research 343 (2008) 2729–2734
2733
J2,NH = 9.0 Hz, NH), 5.21 (t, 1H, J1,2 = J2,3 10.0 Hz, H-2Glc), 5.01–5.06
(m, 2H, H-3Cer, H-4Cer), 4.78 (d, 1H, H-1Glc), 4.63 (2d, 2H, Jgem
H-8Neu), 5.55 (t, 1H, J1,2 8.2 Hz, J2,3 8.2 Hz, H-2Gal), 5.36 (d, 1H, H-
4
1
Gal), 5.24 (dd, 1H, J6,7 2.8 Hz, J7,8 9.2 Hz, H-7Neu), 5.10 (d, 1H, H-
Gal), 5.08 (m, 1H, H-4Cer), 5.02 (d, 1H, J1,2 7.8 Hz, H-2Glc), 4.91–
11.5 Hz, PhCH2), 4.48 (dd, 1H, J5;6 4.0 Hz, Jgem 12.0 Hz, H-60Glc),
0
4.39 (dd, 1H, J5,6 2.0 Hz, H-6Glc), 4.19 (m, 1H, J2,NH 9.0 Hz, H-2Cer),
3.65–3.74 (m, 6H, H-10Cer, H-3Glc, H-4Glc, OMe), 3.54–3.59 (m, 2H,
H-1Cer, H-5Glc), 2.60–2.75 (m, 4H, –OCOCH2CH2COO–), 2.20 (m,
2H, H-6Cer, H-60Cer), 2.15 (s, 3H, OAc), 1.60 (m, 2H, H-5Cer, H-50Cer),
1.20–1.79 (m, 54H, –CH2–), 0.89 (t, 6H, 2Me); 13C NMR
(100 MHz, CDCl3): d 173.3, 172.6, 171.9, 171.5, 165.2, 159.3,
133.2, 132.8, 132.5, 129.83, 129.79, 129.7, 129.0, 128.7, 128.4,
128.2, 127.8, 125.3, 113.7, 86.4, 82.9, 77.8, 74.5, 73.4, 73.2, 72.0,
69.7, 63.3, 61.4, 55.1, 49.6, 36.7, 31.9, 29.7, 29.6, 29.5, 29.34,
29.28, 29.1, 28.6, 25.6, 25.5, 22.7, 20.9, 14.1; HRESIMS: calcd for
C69H105NO14S: 1226.7148 [M+Na]+, found: m/z 1226.7180.
4.98 (m, 3H, H-3Cer, NHNeu, H-3Gal), 4.81 (m, 1H, H-4Neu), 4.66–
4.87 (2d, 2H, Jgem 11.0 Hz, PhCH2), 4.42 (dd, 1H, Jgem 12.4 Hz, H-
90Neu), 4.35 (d, 1H, H-1Glc), 4.14–4.37 (m, 6H, H-5Gal, H-6Gal, H-60Gal
,
H-6Glc, H-60Glc, H-2Cer), 4.05 (dd, 1H, J8,9 6.0 Hz, Jgem 12.4 Hz, H-9Neu),
3.71–3.82 (m, 8H, H-1Cer, H-10Cer, H-3Glc, H-4Glc, H-5Neu, OMe), 3.61
(dd, 1H, H-6Neu), 3.57 (s, 3H, OMe), 3.50 (m, 1H, H-5Glc), 2.36–
2.67 (m, 4H, –OCOCH2CH2COO–), 2.48 (dd, 1H, J3eq.,4 4.6 Hz, H-
3eq.Neu), 1.64 (t, 1H, Jgem 12.4 Hz, H-3ax.Neu), 1.52–2.18 (6s, 18H,
OAc), 1.80 (m, 2H, H-6Cer, H-60Cer), 1.40 (m, 2H, H-5Cer, H-50Cer),
1.10–1.50 (m, 54H, –CH2–), 0.87 (t, 6H, 2Me); 13C NMR
(100 MHz, CDCl3): d 172.8, 171.0, 170.9, 170.8, 170.7, 170.6,
170.3, 170.1, 168.2, 165.7, 165.6, 165.1, 158.8, 133.3, 133.1,
130.4, 130.2, 129.9, 129.8, 129.7, 129.6, 129.4, 128.6, 128.5,
128.3, 113.4, 101.3, 98.8, 96.9, 79.5, 78.7, 77.7, 74.5, 74.4, 73.4,
73.1, 73.1, 72.0, 71.6, 71.4, 70.9, 69.4, 68.2, 67.6, 66.6, 63.3, 62.4,
61.7, 55.0, 53.2, 48.8, 46.6, 37.4, 36.3, 31.9, 30.8, 30.0, 29.7, 29.6,
29.6, 29.5, 29.4, 29.2, 25.3, 25.2, 23.2, 22.7, 21.5, 20.9, 20.8, 20.7,
3.8. 2-O-Benzoyl-3-O-4-methoxybenzyl-b-D-glucopyranosyl-
(1?1)-(2S,3S,4R)-3-O-acetyl-2-octadecanoylamino-octadecane-
4,6-succinate (10)
To a soln of 9 (43 mg, 0.036 mmol) in CH2Cl2 (1.2 mL) was
added MS4Å (40 mg). After stirring for 1 h, NIS (16.0 mg,
20.4, 14.1; HRESIMS: calcd for C110H148N2O34
:
2063.9811
0.071 mmol) and TfOH (0.6
lL, 0.0079 mmol) were added to the
[M+Na]+, found: m/z 2063.9823.
suspension at 0 °C. The mixture was stirred for 5 h at 0 °C. After
completion of the reaction (TLC 1:1 toluene–EtOAc), the mixture
was filtered through Celite. The combined filtrate and washings
were extracted with CHCl3, washed with satd NaHCO3, satd
Na2S2O3 and brine, dried (Na2SO4) and concentrated. The residue
was chromatographed on a column of silica gel (3:1 toluene–
3.10. O-(5-Acetamido-3,5-dideoxy-
nonulopyranosylonic acid)-(2?3)-(O-b-
(1?4)-O-b- -glucopyranosyl-(1?1)-(2S,3S,4R)-2-
D
-glycero-
a-D-galacto-2-
D-galactopyranosyl)-
D
octadecanoylamino-octadecane-1,3,4-triol (14)
EtOAc) to give 10 (33 mg, 85%) as an amorphous solid: [
a
]
+3.7
To a soln of 12 (38 mg, 0.0184 mmol) in CH2Cl2 (800 lL) was
added trifluoroacetic acid (370 lL). The mixture was stirred for
7 h at room temperature. After complete consumption of the start-
ing material (TLC 6:1 EtOAc–hexane), Et3N was added at 0 °C. The
reaction mixture was co-evaporated with toluene. After concentra-
tion, the residue was dissolved in MeOH (1.0 mL) and NaOMe
D
(c 1.1, CHCl3); 1H NMR (500 MHz, CDCl3): d 7.40–8.05 (m, 5H,
Ph), 6.75–7.12 (2d, 4H, MeOPh), 6.02 (d, 1H, J2,NH 9.0 Hz, NH),
5.18 (m, 2H, J1,2 7.5 Hz, H-4Cer, H-2Glc), 5.10 (t, 1H, H-3Cer), 4.66
(d, 1H, Jgem 11.5 Hz, PhCH2), 4.55 (d, 1H, PhCH2), 4.47 (d, 1H, H-
1
Glc), 4.39 (d, 1H, J1,2 5.5 Hz, H-2Cer), 4.37–4.41 (m, 2H, H-6Glc, H-
60Glc), 3.81 (dd, 1H, Jgem 11.5 Hz, H-1Cer), 3.73 (s, 3H, OMe), 3.61–
(7.2 mM soln in MeOH, 100 lL, 5.2 lmol) was added at 0 °C. After
3.69 (m, 3H, H-10Cer, H-3Glc, H-5Glc), 3.49 (dt, 1H, J4,4-OH 2.0 Hz, H-
stirring at room temperature for 26 h (TLC monitoring: 10:1:1
BuOH–MeOH–water), water was added to the mixture at 0 °C.
The mixture was stirred at room temperature for 10 h (TLC moni-
toring: 10:1:1 BuOH–MeOH–water). The reaction mixture was
neutralized with Dowex (H+) and filtered. The combined filtrate
and washings were concentrated. Column chromatography
(MeOH) of the residue on Sephadex LH-20 (200 g) gave 14
4
Glc), 2.50–2.80 (m, 4H, –OCOCH2CH2COO–), 2.50 (d, 1H, 4-OHGlc),
2.10 (s, 3H, OAc), 2.00 (m, 2H, H-6Cer, H-60Cer), 1.50 (m, 2H, H-5Cer
,
H-50Cer), 1.10–1.60 (m, 54H, –CH2–), 0.84 (t, 6H, 2Me); 13C NMR
(100 MHz, CDCl3): d 172.9, 171.4, 171.2, 170.8, 165.0, 159.3,
133.3, 129.8, 129.7, 129.6, 129.5, 128.5, 114.0, 113.9, 100.1, 81.5,
74.7, 74.3, 73.8, 73.7, 72.7, 70.4, 63.8, 55.1, 47.4, 37.4, 37.1, 36.5,
33.5, 32.7, 31.9, 30.2, 30.0, 29.7, 29.64, 29.55, 29.52, 29.48, 29.4,
29.34, 29.32, 29.2, 27.4, 27.1, 25.4, 25.0, 24.4, 22.7, 21.0, 19.7,
14.1; HRESIMS: calcd for C63H99NO14: 1116.6963 [M+Na]+, found:
m/z 1116.6923.
(22.1 mg, quantitative) as an amorphous solid: [
a
]
+8.0 (c 1.0,
D
MeOH); 1H NMR (600 MHz, CD3OD): d 4.42 (d, 1H, J1,2 7.6 Hz, H-
1
Gal), 4.31 (d, 1H, J1,2 7.6 Hz, H-1Glc), 2.85 (dd, 1H, Jgem 11.7 Hz, H-
3eq.Neu), 2.20 (m, 2H, H-6Cer, H-60Cer), 2.00 (s, 3H, NAc), 1.73 (t,
1H, H-3ax.Neu), 1.50 (m, 2H, H-5Cer, H-50Cer), 1.10–1.70 (m, 54H, –
CH2–), 0.90 (t, 6H, 2Me); 13C NMR (150 MHz, CD3OD): d 176.0,
175.5, 175.0, 105.1, 104.5, 101.1, 80.9, 77.7, 77.1, 76.5, 76.2, 75.1,
75.0, 74.8, 73.1, 73.0, 70.9, 70.2, 70.1, 69.4, 69.0, 64.6, 62.7, 61.8,
54.0, 51.9, 49.9, 49.6, 42.1, 37.3, 33.1, 32.3, 30.9, 30.9, 30.8, 30.8,
30.7, 30.6, 30.5, 30.5, 30.4, 27.1, 23.7, 22.6, 14.4; HRESIMS: calcd
for C59H110N2O22: 1221.7442 [M+Na]+, found: m/z 1221.7450.
3.9. (Methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-
glycero- -galacto-2-nonulopyranosylonate)-(2?3)-(2,4,6-tri-
O-benzoyl-b- -galactopyranosyl)-(1?4)-2-O-benzoyl-3-O-4-
methoxybenzyl-b- -glucopyranosyl-(1?1)-(2S,3S,4R)-3-O-
acetyl-2-octadecanoylamino-octadecane-4,6-succinate (12)
D-
a-D
D
D
To
0.137 mmol) in CH2Cl2 (1.1 mL) were added molecular sieves
(AW-300) (200 mg). After stirring for 1 h, TMSOTf (1.0 L,
a soln of 10 (63 mg, 0.0578 mmol) and 11 (152 mg,
Acknowledgements
l
0.00548 mmol) was added to the suspension at 0 °C. The progress
of the reaction was monitored by TLC (1:3 toluene–EtOAc). After
stirring for 4 h at 0 °C, the reaction mixture was filtered through
a pad of Celite. The combined filtrate and washings were extracted
with CHCl3, and washed with satd NaHCO3, and brine, dried
(Na2SO4) and concentrated. The residue was chromatographed on
a column of silica gel (1:2 toluene–EtOAc) to give 12 (83 mg,
This work was partly supported by the Ministry of Education,
Culture, Sports, Science, and Technology (MEXT) of Japan (Grant-
in-Aid for Scientific Research to M. Kiso, No. 17101007). We thank
Dr. Hirofumi Dohi for helpful discussions and Ms. Kiyoko Ito for
technical assistance.
References
70%) as an amorphous solid: [a]
+24.4 (c 0.7, CHCl3); 1H NMR
D
1. Hakomori, S. J. Biol. Chem. 1990, 265, 18713–18716.
2. Schnaar, R. L. Glycobiology 1991, 1, 477–485.
(400 MHz, CDCl3): d 7.34–8.21 (m, 20H, 4Ph), 6.43–7.01 (2d, 4H,
MeOPh), 5.94 (d, 1H, J2,NH 8.2 Hz, NHCer), 5.68 (m, 1H, J7,8 9.2 Hz,